|
|
| (41 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| {{DrugProjectFormSinglePage
| | #REDIRECT [[Interferon beta-1b]] |
| |genericName=Interferon Beta-1B
| |
| |aOrAn=an
| |
| |drugClass=immunologic adjuvant
| |
| |indicationType=treatment
| |
| |indication=relapsing forms of [[multiple sclerosis]]
| |
| |adverseReactions=injection site reaction, [[lymphopenia]], [[flu]]-like symptoms, [[myalgia]], l[[eukopenia]], [[neutropenia]], increased liver enzymes, [[headache]], [[hypertonia]], pain, [[rash]], [[insomnia]], [[abdominal pain]], and [[asthenia]]
| |
| |blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b>
| |
| |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content)
| |
| |fdaLIADAdult=====Multiple Sclerosis====
| |
| | |
| BETASERON (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
| |
| | |
| * Dosing Information
| |
| :* The recommended starting dose is 0.0625 mg (0.25 mL) subcutaneously every other day, with dose increases over a six week period to the recommended dose of 0.25 mg (1 mL) every other day
| |
| |offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Interferon Beta-1B in adult patients.
| |
| |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Interferon Beta-1B in adult patients.
| |
| |fdaLIADPed=Safety and efficacy in pediatric patients have not been established.
| |
| |offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Interferon Beta-1B in pediatric patients.
| |
| |offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Interferon Beta-1B in pediatric patients.
| |
| |alcohol=Alcohol-Interferon Beta-1B interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
| |
| }}
| |